Search bioRxiv⌕ Search

bioRxiv · 10.1101/2020.11.23.393660

Nuclear Morphology Optimized Deep Hybrid Learning (NUMODRIL): A novel architecture for accurate diagnosis/prognosis of Ovarian Cancer

Abstract

Nuclear morphological features are potent determining factors for clinical diagnostic approaches adopted by pathologists to analyse the malignant potential of cancer cells. Considering the structural alteration of nucleus in cancer cells, various groups have developed machine learning techniques based on variation in nuclear morphometric information like nuclear shape, size, nucleus-cytoplasm ratio and various non-parametric methods like deep learning have also been tested for analysing immunohistochemistry images of tissue samples for diagnosing various cancers. Our aim is to study the morphometric distribution of nuclear lamin proteins as a specific parameter in ovarian cancer tissues. Besides being the principal mechanical component of the nucleus, lamins also present a platform for binding of proteins and chromatin thereby serving a wide range of nuclear functions like maintenance of genome stability, chromatin regulation. Altered expression of lamins in different subtypes of cancer is now evident from data across the world. It has already been elucidated that in ovarian cancer, extent of alteration in nuclear shape and morphology can determine degree of genetic changes and thus can be utilized to predict the outcome of low to high form of serous carcinoma. In this work, we have performed exhaustive imaging of ovarian cancer versus normal tissue and introduced a novel Deep Hybrid Learning approach on the basis of the distribution of lamin proteins. Although developed with ovarian cancer datasets in view, this architecture would be of immense importance in accurate and fast diagnosis and prognosis of all types of cancer associated with lamin induced morphological changes and would perform across small/medium to large datasets with equal efficiency. Significance StatementWe have developed a novel Deep Hybrid Learning approach based on nuclear morphology to classify normal and ovarian cancer tissues with highest possible accuracy and speed. Ovarian cancer cells can be easily distinguished from their enlarged nuclear morphology as is evident from lamin A & B distribution pattern. This is the first report to invoke specific nuclear markers like lamin A & B instead of classical haematoxylin-eosin staining in an effort to build parametric datasets. Our approach has been shown to outperform the existing deep learning techniques in training and validation of datasets over a wide range. Therefore this method could be used as a robust model to predict malignant transformations of benign nuclei and thus be implemented in the diagnosis and prognosis of ovarian cancer in future. Most importantly, this method can be perceived as a generalized approach in the diagnosis for all types of cancer.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sengupta, D., Ali, S. N., Bhattacharya, A., Mustafi, J., Mukhopadhyay, A., SENGUPTA, K.. 2020-11-23. Nuclear Morphology Optimized Deep Hybrid Learning (NUMODRIL): A novel architecture for accurate diagnosis/prognosis of Ovarian Cancer. https://doi.org/10.1101/2020.11.23.393660

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Ex vivo human tumor slices more accurately predict patient responses to an oncolytic virus than in vivo mouse models

Immunotherapies, including oncolytic viruses (OV), are promising therapies that can enhance anti-tumor immune responses. However, preclinical success of immunotherapies in mouse models has not always translated to clinical benefit in cancer patients. This study compared preclinical efficacy and mechanism of action for ASP9801, a vaccinia virus expressing IL-7 and IL-12, using mouse models of colorectal cancer (CRC) in vivo and in human organotypic tumor slice models ex vivo. The murine surrogate for ASP9801 significantly reduced tumor volumes in treated and abscopal tumors in two different CRC models in vivo (MC38 and RO100). Treatment efficacy was accentuated when combined with anti-PD1 treatment, and single-cell RNA sequencing analysis revealed depletion of tumor cells and increased T cell infiltration and activation in both treated and abscopal tumors. However, human tissue analysis ex vivo (E-slices) using PDX models and patient samples showed that ASP9801 is not effective in CRC, consistent with clinical trial results. On the other hand, ASP9801 was highly effective in GBM, indicating indication-specific efficacy of ASP9801, and how E-slice assays can be used to identify treatment-sensitive indications. This study demonstrates the superiority of E-slices over mouse models for predicting clinical response and its utility in planning clinical trials.

cancer biology↗

Immune-cell depleted diffuse large B-cell lymphomas have reduced expression of MHC class I

Immunotherapy has transformed treatment for many cancers. In the aggressive and genetically heterogeneous diffuse large B-cell lymphoma (DLBCL), CD19 CAR T-cell therapy is highly effective, whereas immune checkpoint blockade has shown limited benefit. Loss of MHC expression is a common mechanism to escape T-cell cytotoxicity, and loss of MHC class I (MHC-I) and II are frequent in DLBCL. We applied imaging mass cytometry to diagnostic biopsies from younger, high-risk DLBCL patients to map the tumor microenvironment (TME) spatial architecture in relation to tumor cell MHC expression, mutational status, transcriptomic and proteomic profiles. Neighborhood analyses identified four TME subtypes: immune-cell depleted and three immune-infiltrated types (mixed, CD4 T cell-rich, CD8 T-cell/macrophage-rich). Depleted cases had shorter overall survival (p = 0.033) and increased expression of proteins involved in DNA replication and proliferation markers compared to infiltrated cases. Tumor cell MHC-I expression was heterogeneous. Cases with low frequency of MHC-I-pos tumor cells were enriched for the depleted TME type. MHC-I-pos tumor cells were surrounded by CD4 and CD8 T cells and M1 macrophages, whereas MHC-I-neg tumor cells were closer to other MHC-I-neg tumor cells. These findings suggest that TME-based classification incorporating tumor cell MHC-I status may improve individualized immunotherapy selection.

cancer biology↗

Cross-species analysis links cell-cell communication rewiring to NOTCH2 during serous endometrial carcinogenesis

Cell-cell interactions shape the fate of mutant cells during cancer initiation but how these interactions evolve during progression to pathologically recognizable lesions remain poorly understood. Here, we investigated cell-cell communication during serous endometrial carcinoma (SEC; also known as uterine serous carcinoma) development using a lineage-traceable mouse model and cross-species analyses of the mouse and human neoplastic endometrium. In mice, the early, pre-dysplastic stage was marked by a global decrease in inferred cell-cell interactions, followed by extensive communication network rewiring during neoplastic progression. Pathway-specific analysis revealed a similar pattern for NOTCH signaling, with NOTCH2 emerging as the dominant NOTCH receptor in Trp53/Rb1-mutant immature epithelial cells. Functionally, NOTCH2 promoted the outgrowth of more proliferative mutant organoids. Cross-species transcriptomic analysis identified conserved immature epithelial states in mouse and human neoplastic endometrial epithelium. In human tissues, NOTCH2 was overexpressed in serous endometrial intraepithelial carcinoma, a precursor of SEC, and in overt SEC. Furthermore, elevated NOTCH2 expression was associated with poor patient survival. These findings link cell-cell communication rewiring during experimental SEC development to conserved neoplastic epithelial states and identify NOTCH2 as an early marker and a potential target of disease interception.

cancer biology↗